Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 14 of 27.
- T49.2X5DAdverse effect of local astringents and local detergents, subsequent encounter
- T49.2X5SAdverse effect of local astringents and local detergents, sequela
- T49.2X6AUnderdosing of local astringents and local detergents, initial encounter
- T49.2X6DUnderdosing of local astringents and local detergents, subsequent encounter
- T49.2X6SUnderdosing of local astringents and local detergents, sequela
- T49.3X5AAdverse effect of emollients, demulcents and protectants, initial encounter
- T49.3X5DAdverse effect of emollients, demulcents and protectants, subsequent encounter
- T49.3X5SAdverse effect of emollients, demulcents and protectants, sequela
- T49.3X6AUnderdosing of emollients, demulcents and protectants, initial encounter
- T49.3X6DUnderdosing of emollients, demulcents and protectants, subsequent encounter
- T49.3X6SUnderdosing of emollients, demulcents and protectants, sequela
- T49.4X5AAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.4X5DAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
- T49.4X5SAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
- T49.4X6AUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.4X6DUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
- T49.4X6SUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
- T49.5X5AAdverse effect of ophthalmological drugs and preparations, initial encounter
- T49.5X5DAdverse effect of ophthalmological drugs and preparations, subsequent encounter
- T49.5X5SAdverse effect of ophthalmological drugs and preparations, sequela
- T49.5X6AUnderdosing of ophthalmological drugs and preparations, initial encounter
- T49.5X6DUnderdosing of ophthalmological drugs and preparations, subsequent encounter
- T49.5X6SUnderdosing of ophthalmological drugs and preparations, sequela
- T49.6X5AAdverse effect of otorhinolaryngological drugs and preparations, initial encounter
- T49.6X5DAdverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
- T49.6X5SAdverse effect of otorhinolaryngological drugs and preparations, sequela
- T49.6X6AUnderdosing of otorhinolaryngological drugs and preparations, initial encounter
- T49.6X6DUnderdosing of otorhinolaryngological drugs and preparations, subsequent encounter
- T49.6X6SUnderdosing of otorhinolaryngological drugs and preparations, sequela
- T49.7X5AAdverse effect of dental drugs, topically applied, initial encounter
- T49.7X5DAdverse effect of dental drugs, topically applied, subsequent encounter
- T49.7X5SAdverse effect of dental drugs, topically applied, sequela
- T49.7X6AUnderdosing of dental drugs, topically applied, initial encounter
- T49.7X6DUnderdosing of dental drugs, topically applied, subsequent encounter
- T49.7X6SUnderdosing of dental drugs, topically applied, sequela
- T49.8X5AAdverse effect of other topical agents, initial encounter
- T49.8X5DAdverse effect of other topical agents, subsequent encounter
- T49.8X5SAdverse effect of other topical agents, sequela
- T49.8X6AUnderdosing of other topical agents, initial encounter
- T49.8X6DUnderdosing of other topical agents, subsequent encounter
- T49.8X6SUnderdosing of other topical agents, sequela
- T49.95XAAdverse effect of unspecified topical agent, initial encounter
- T49.95XDAdverse effect of unspecified topical agent, subsequent encounter
- T49.95XSAdverse effect of unspecified topical agent, sequela
- T49.96XAUnderdosing of unspecified topical agent, initial encounter
- T49.96XDUnderdosing of unspecified topical agent, subsequent encounter
- T49.96XSUnderdosing of unspecified topical agent, sequela
- T50.0X5AAdverse effect of mineralocorticoids and their antagonists, initial encounter
- T50.0X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounter
- T50.0X5SAdverse effect of mineralocorticoids and their antagonists, sequela
- T50.0X6AUnderdosing of mineralocorticoids and their antagonists, initial encounter
- T50.0X6DUnderdosing of mineralocorticoids and their antagonists, subsequent encounter
- T50.0X6SUnderdosing of mineralocorticoids and their antagonists, sequela
- T50.1X5AAdverse effect of loop [high-ceiling] diuretics, initial encounter
- T50.1X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounter
- T50.1X5SAdverse effect of loop [high-ceiling] diuretics, sequela
- T50.1X6AUnderdosing of loop [high-ceiling] diuretics, initial encounter
- T50.1X6DUnderdosing of loop [high-ceiling] diuretics, subsequent encounter
- T50.1X6SUnderdosing of loop [high-ceiling] diuretics, sequela
- T50.2X5AAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.2X5DAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
- T50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
- T50.2X6AUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
- T50.2X6DUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
- T50.2X6SUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
- T50.3X5AAdverse effect of electrolytic, caloric and water-balance agents, initial encounter
- T50.3X5DAdverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
- T50.3X5SAdverse effect of electrolytic, caloric and water-balance agents, sequela
- T50.3X6AUnderdosing of electrolytic, caloric and water-balance agents, initial encounter
- T50.3X6DUnderdosing of electrolytic, caloric and water-balance agents, subsequent encounter
- T50.3X6SUnderdosing of electrolytic, caloric and water-balance agents, sequela
- T50.4X5AAdverse effect of drugs affecting uric acid metabolism, initial encounter
- T50.4X5DAdverse effect of drugs affecting uric acid metabolism, subsequent encounter
- T50.4X5SAdverse effect of drugs affecting uric acid metabolism, sequela
- T50.4X6AUnderdosing of drugs affecting uric acid metabolism, initial encounter
- T50.4X6DUnderdosing of drugs affecting uric acid metabolism, subsequent encounter
- T50.4X6SUnderdosing of drugs affecting uric acid metabolism, sequela
- T50.5X5AAdverse effect of appetite depressants, initial encounter
- T50.5X5DAdverse effect of appetite depressants, subsequent encounter
- T50.5X5SAdverse effect of appetite depressants, sequela
- T50.5X6AUnderdosing of appetite depressants, initial encounter
- T50.5X6DUnderdosing of appetite depressants, subsequent encounter
- T50.5X6SUnderdosing of appetite depressants, sequela
- T50.6X5AAdverse effect of antidotes and chelating agents, initial encounter
- T50.6X5DAdverse effect of antidotes and chelating agents, subsequent encounter
- T50.6X5SAdverse effect of antidotes and chelating agents, sequela
- T50.6X6AUnderdosing of antidotes and chelating agents, initial encounter
- T50.6X6DUnderdosing of antidotes and chelating agents, subsequent encounter
- T50.6X6SUnderdosing of antidotes and chelating agents, sequela
- T50.7X5AAdverse effect of analeptics and opioid receptor antagonists, initial encounter
- T50.7X5DAdverse effect of analeptics and opioid receptor antagonists, subsequent encounter
- T50.7X5SAdverse effect of analeptics and opioid receptor antagonists, sequela
- T50.7X6AUnderdosing of analeptics and opioid receptor antagonists, initial encounter
- T50.7X6DUnderdosing of analeptics and opioid receptor antagonists, subsequent encounter
- T50.7X6SUnderdosing of analeptics and opioid receptor antagonists, sequela
- T50.8X5AAdverse effect of diagnostic agents, initial encounter
- T50.8X5DAdverse effect of diagnostic agents, subsequent encounter
- T50.8X5SAdverse effect of diagnostic agents, sequela
- T50.8X6AUnderdosing of diagnostic agents, initial encounter
- T50.8X6DUnderdosing of diagnostic agents, subsequent encounter